PrasannaJagannathanMD

Infectious Disease • Stanford, CA

Assistant Professor, Medicine, University of California, San Francisco, School of

Join to view full profile

Dr. Jagannathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jagannathan's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Education & Training

University of California (San Francisco)Fellowship, Infectious Disease, 2009 - 2011
University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
Harvard Medical SchoolClass of 2005

Certifications & Licensure

CA State Medical License 2007 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual parti...
Michelle E Roh, Julie Gutman, Maxwell Murphy, Jenny Hill, Mywayiwawo Madanitsa
Medrxiv. 2024-11-26
Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution.
Rebecca E Hamlin, Shaun M Pienkos, Leslie Chan, Mikayla A Stabile, Kassandra Pinedo
Science Translational Medicine. 2024-11-13
Gestational SARS-CoV-2 Infection in a Ugandan Birth Cohort: High Incidence, Mild Maternal Disease, and Evidence of Association with Transient Infant Stunting.
Karen B Jacobson, Katharina Röltgen, Brandon Lam, Patience Nayebare, Abel Kakuru
The American Journal of Tropical Medicine and Hygiene. 2024-11-06

Journal Articles

Dihydroartemisinin-Piperaquine for Intermittent Preventive Treatment of Malaria During Pregnancy and Risk of Malaria in Early Childhood: A Randomized Controlled Trial
Bryan Greenhouse, Prasanna Jagannathan, Diane V Havlir, PLoS One

Press Mentions

I Didn’t Take Paxlovid and Got Rebound COVID Anyway. Did I Make the Wrong Call?September 5th, 2022
Paxlovid for COVID-19: Important InformationJuly 14th, 2022
Paxlovid: Your Questions About the Antiviral COVID-19 Pill Treatment, AnsweredJuly 14th, 2022
Join now to see all